Search Results - "Ounnoughene, N"

Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience by Rossi, B., Blanche, P., Roussel-Robert, V., Berezné, A., Combe, S., Coppo, P., Guillevin, L., Le Jeunne, C., Mouthon, L., Ounnoughene, N., Stieltjes, N., Groh, M.

Get full text

The blood donors' haemovigilance in France by Ounnoughene, N, Sandid, I, Carlier, M, Joussemet, M, Ferry, N

“…This work aim to present the descriptive analysis of serious adverse reactions in donors (dSAR's), which were notified in 2010 and 2011 in the French national…”
Get more information

Seventeen years of haemovigilance in France: assessment and outlook by Carlier, M, Vo Mai, M-P, Fauveau, L, Ounnoughene, N, Sandid, I, Renaudier, P

“…Since 1994, the French haemovigilance network has not stopped evolving. Based initially on the reporting of informations and incidents related to recipients,…”
Get more information

Factsheets: support in the analysis of recipients' adverse reactions by Bazin, A, Trophilme, C, Py, J-Y, Caldani, C, Daurat, G, Hauser, L, Leconte des Floris, M-F, Moncharmont, P, Pillonel, J, Renaudier, P, Richomme, X, Sailliol, A, Boudjedir, K, Ounnoughene, N, Sandid, I, Vo-Mai, M-P, Carlier, M

“…In order to help the analysis of adverse effects of transfusion, factsheets have been written by working groups of the French agency for the safety of health…”
Get more information

L’hémovigilance des donneurs de sang en France by Ounnoughene, N., Sandid, I., Carlier, M., Joussemet, M., Ferry, N.

“…Le travail exposé dans ce document a pour objectif l’analyse descriptive des déclarations des effets indésirables graves donneurs (EIGD) recensées en 2010 et…”
Get full text

Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience by Goudemand, J, Negrier, C, Ounnoughene, N, Sultan, Y

“…Part of the French clinical experience using the solvent/detergent (S/D) treated VHP von Willebrand factor (vWF) concentrate (LFB, Les Ulis, France)…”
Get full text

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications by Magli-Barioz, D., Ounnoughène, N., Paugy, P., Quarrè, M.-C., Vassilief, D., Lopez, I., Goudemand, J., Negrier, C., Assogba, U., Driss, F., A.-Dumont, M., Molho, P.

“…The aims of the study were to evaluate the impact of a written information about treatment related risks in patient receiving blood derived or recombinant…”
Get full text

Les infections bactériennes transmises par transfusion avec imputabilité 2 du PSL : analyse rétrospective de la base e-FIT de 2000 à 2007 by Delbosc, A., Lafeuillade, B., Petermann, R., Eb, F., Ounnoughene, N.

“…Une infection bactérienne transmise par transfusion est un effet indésirable survenu chez un receveur de produits sanguins labiles, survenant au cours ou au…”
Get full text

Dix-sept ans d’hémovigilance en France : bilan, perspectives by Carlier, M., Vo Mai, M.-P., Fauveau, L., Ounnoughene, N., Sandid, I., Renaudier, P.

“…Depuis sa mise en place en 1994, le système français d’hémovigilance n’a cessé d’évoluer. Reposant initialement sur le signalement et la déclaration…”
Get full text

Fiches techniques : aide à l’analyse des effets indésirables receveurs by Bazin, A., Trophilme, C., Py, J.-Y., Caldani, C., Daurat, G., Hauser, L., Leconte des Floris, M.-F., Moncharmont, P., Pillonel, J., Renaudier, P., Richomme, X., Sailliol, A., Boudjedir, K., Ounnoughene, N., Sandid, I., Vo-Mai, M.-P., Carlier, M.

“…Afin d’aider à l’analyse des effets indésirables survenant chez les patients receveurs de produits sanguins labiles, des fiches techniques ont été élaborées à…”
Get full text

OC 43.3 Surgery in People with Hemophilia a Receiving Emicizumab Prophylaxis: Real-World Experience from a Single French Reference Center of Hemophilia by Brakta, C., Stieltjes, N., Combe, S., Ounnoughene, N., Duchemin, J., Capdevila, L., Goubeau, L., Fontenay, M., Roussel Robert, V., Proulle, V.

Get full text

Complications pulmonaires de la transfusion (TACO–TRALI) by Renaudier, P., Rebibo, D., Waller, C., Schlanger, S., Vo Mai, M.-P., Ounnoughene, N., Breton, P., Cheze, S., Girard, A., Hauser, L., Legras, J.-F., Saillol, A., Willaert, B., Caldani, C.

“…Les œdèmes pulmonaires survenant pendant ou après une transfusion figurent parmi les accidents graves les plus fréquents, dans le système français…”
Get full text

Évaluation de l'organisation du dépistage sérologique pré- et post-transfusionnel en France en 2001 by Fressy, P., Daurat, G., Duedari, N., Le Blanc, G., Taverne, D., Ounnoughène, N., Pillonel, J.

“…La réglementation prévoit en France que les établissements de santé recueillent et conservent toutes les informations relatives à l'hémovigilance et notamment…”
Get full text

Évaluation médicoéconomique du suivi sérologique péritransfusionnel du virus de l’hépatite C by Josset, V., Chamouni, P., Tavolacci, M.P., Merle, V., Delbos, V., Froment, L., Ladner, J., Ounnoughene, N., Czernichow, P.

“…Le dépistage péri transfusionnel du virus de l'hépatite C justifie une évaluation médicoéconomique. Méthodes. – Quatre stratégies de dépistage péri…”
Get full text

Évaluation du dépistage sérologique pré- et post-transfusionnel en France en 2001 by Daurat, G., Fressy, P., Duedari, N., Le Blanc, G., Taverne, D., Ounnoughène, N., Pillonel, J.

“…Le dépistage VIH et VHC chez les receveurs de produits sanguins labiles a été recommandé en 1996 en France par circulaire ministérielle. Appliqué en…”
Get full text

A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis by MOLHO, P., VERRIER, P., STIELTJES, N., SCHACHER, J.-M., OUNNOUGHÈNE, N., VASSILIEFF, D., MENKES, C.-J., SULTAN, Y.

“…Between 1970 and 1994, 116 chemical and 90 radioactive synovectomies were performed in 107 patients with severe haemophilia and two with type 3 von…”
Get full text

Effect of tamoxifen on von Willebrand factor levels by Ounnoughène, N, Molho, P, Stieltjes, N, Sultan, Y

Get more information

Evaluation of the organization of pre and post transfusion screening of viral infection markers in blood recipients in France in 2001 by Fressy, P, Daurat, G, Duedari, N, Le Blanc, G, Taverne, D, Ounnoughène, N, Pillonel, J

“…In France, data collection related to blood recipient's viral infectious disease markers pre and post-transfusion is a legal requirement for hospitals. Our…”
Get full text

Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion by Leclercq, Alexandre, Martin, Liliane, Vergnes, Maya Laporte, Ounnoughene, Nadra, Laran, Jean-François, Giraud, Patrick, Carniel, Elisabeth

“…BACKGROUND: Although posttransfusion bacterial sepsis is rare, this complication is associated with a high mortality rate. CASE REPORT: A fatal case of septic…”
Get full text

FACTEUR WILLEBRAND-LFB® : Expérience clinique by GOUDEMAND, J, NEGRIER, C, OUNNOUGHENE, N, SULTAN, Y

Get full text